Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of apixaban 5 mg tablets in healthy Thai volunteers
TCTR20201216004Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of apixaban (2 arms), sponsored by International Bio Service. Primary endpoints: Cmax, AUC0-tlast and 1 more. Planned start Mar 2021; status: not yet recruiting.
02
Drugs
apixaban
Beyond the preview
Go deeper on TCTR20201216004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201216004.